About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 354979, 6 pages
http://dx.doi.org/10.1155/2012/354979
Review Article

Ocriplasmin for Vitreoretinal Diseases

Retina Division, Jules Stein Eye Institute, University of California, Los Angeles, CA 90095, USA

Received 27 March 2012; Accepted 6 June 2012

Academic Editor: Lindsey A. Miles

Copyright © 2012 Irena Tsui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Sebag and E. A. Balazs, “Morphology and ultrastructure of human vitreous fibers,” Investigative Ophthalmology and Visual Science, vol. 30, no. 8, pp. 1867–1871, 1989. View at Scopus
  2. N. Yamada and S. Kishi, “Tomographic features and surgical outcomes of vitreomacular traction syndrome,” American Journal of Ophthalmology, vol. 139, no. 1, pp. 112–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. L. K. Chang, H. F. Fine, R. F. Spaide, H. Koizumi, and H. E. Grossniklaus, “Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome,” American Journal of Ophthalmology, vol. 146, no. 1, pp. 121–127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Gandorfer, “Enzymatic vitreous disruption,” Eye, vol. 22, no. 10, pp. 1273–1277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Udaondo, M. Diaz-Llopis, S. Garcia-Delpech, D. Salom, and J. F. Arevalo, “Microplasmin for vitreomacular traction,” Ophthalmology, vol. 117, no. 9, pp. 1859–1860, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Gandorfer, “Objective of pharmacologic vitreolysis,” Developments in Ophthalmology, vol. 44, pp. 1–6, 2009. View at Scopus
  7. M. D. de Smet, A. Gandorfer, P. Stalmans et al., “Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: the MIVI I trial,” Ophthalmology, vol. 116, no. 7, pp. 1349–1355.e2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. A. Liotta, R. H. Goldfarb, and R. Brundage, “Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane,” Cancer Research, vol. 41, no. 11, part 1, pp. 4629–4636, 1981. View at Scopus
  9. M. Hermel, W. Dailey, and M. K. Hartzer, “Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery,” Current Eye Research, vol. 35, no. 5, pp. 419–424, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Papp, T. Kovacs, and I. Lerant, “Conditions of formation of the heparin-fibronectin-collagen complex and the effect of plasmin,” Biochimica et Biophysica Acta, vol. 925, no. 3, pp. 241–247, 1987. View at Scopus
  11. X. Li, X. Shi, and J. Fan, “Posterior vitreous detachment with plasmin in the isolated human eye,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 240, no. 1, pp. 56–62, 2002. View at Scopus
  12. W. Chen, W. Mo, K. Sun, X. Huang, Y. L. Zhang, and H. Y. Song, “Microplasmin degrades fibronectin and laminin at vitreoretinal interface and outer retina during enzymatic vitrectomy,” Current Eye Research, vol. 34, no. 12, pp. 1057–1064, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Uemura, M. Nakamura, S. Kachi et al., “Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy,” Archives of Ophthalmology, vol. 123, no. 2, pp. 209–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kohno, N. Sorgente, and T. Ishibashi, “Immunofluorescent studies of fibronectin and laminin in the human eye,” Investigative Ophthalmology and Visual Science, vol. 28, no. 3, pp. 506–514, 1987. View at Scopus
  15. T. Kohno, N. Sorgente, R. Patterson, and S. J. Ryan, “Fibronectin and laminin distribution in bovine eye,” Japanese Journal of Ophthalmology, vol. 27, no. 3, pp. 496–505, 1983. View at Scopus
  16. S. R. Russell, J. D. Shepherd, and G. S. Hageman, “Distribution of glycoconjugates in the human retinal internal limiting membrane,” Investigative Ophthalmology and Visual Science, vol. 32, no. 7, pp. 1986–1995, 1991. View at Scopus
  17. T. Kohno, N. Sorgente, R. Goodnight, and S. J. Ryan, “Alterations in the distribution of fibronectin and laminin in the diabetic human eye,” Investigative Ophthalmology and Visual Science, vol. 28, no. 3, pp. 515–521, 1987. View at Scopus
  18. T. C. Verstraeten, C. Chapman, M. Hartzer, B. S. Winkler, M. T. Trese, and G. A. Williams, “Pharmacologic induction of posterior vitreous detachment in the rabbit,” Archives of Ophthalmology, vol. 111, no. 6, pp. 849–854, 1993. View at Scopus
  19. T. Hikichi, N. Yanagiya, M. Kado, J. Akiba, and A. Yoshida, “Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous,” Retina, vol. 19, no. 1, pp. 55–58, 1999. View at Scopus
  20. N. J. Kim, H. G. Yu, Y. S. Yu, and H. Chung, “Long-term effect of plasmin on the vitreolysis in rabbit eyes,” Korean Journal of Ophthalmology, vol. 18, no. 1, pp. 35–40, 2004. View at Scopus
  21. A. Gandorfer, E. Putz, U. Welge-Lüßen, M. Grüterich, M. Ulbig, and A. Kampik, “Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy,” British Journal of Ophthalmology, vol. 85, no. 1, pp. 6–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Gandorfer, S. Priglinger, K. Schebitz et al., “Vitreoretinal morphology of plasmin-treated human eyes,” American Journal of Ophthalmology, vol. 133, no. 1, pp. 156–159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Li, X. Shi, and J. Fan, “Posterior vitreous detachment with plasmin in the isolated human eye,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 240, no. 1, pp. 56–62, 2002. View at Scopus
  24. A. Uemura, M. Nakamura, S. Kachi et al., “Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy,” Archives of Ophthalmology, vol. 123, no. 2, pp. 209–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Plantner, A. Smine, and T. A. Quinn, “Matrix metalloproteinases and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous,” Current Eye Research, vol. 17, no. 2, pp. 132–140, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Takano, A. Hirata, Y. Inomata et al., “Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous,” American Journal of Ophthalmology, vol. 140, no. 4, pp. 654–660, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. J. Brown, P. Bishop, H. Hamdi, and M. C. Kenney, “Cleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2,” Current Eye Research, vol. 15, no. 4, pp. 439–445, 1996. View at Scopus
  28. S. Monea, K. Lehti, J. Keski-Oja, and P. Mignatti, “Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism,” Journal of Cellular Physiology, vol. 192, no. 2, pp. 160–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Gandorfer and A. Kampik, “Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous,” American Journal of Ophthalmology, vol. 141, no. 4, pp. 784–785, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Sivak and M. E. Fini, “MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology,” Progress in Retinal and Eye Research, vol. 21, no. 1, pp. 1–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Staubach, V. Nober, and P. Janknecht, “Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin,” Current Eye Research, vol. 29, no. 4-5, pp. 261–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Hermel, J. Prenner, M. Alabdulrazzak, W. Dailey, and M. Hartzer, “Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 3, pp. 331–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. W. C. Wu, K. A. Drenser, M. T. Trese, G. A. Williams, and A. Capone, “Pediatric traumatic macular hole: results of autologous plasmin enzyme-assisted vitrectomy,” American Journal of Ophthalmology, vol. 144, no. 5, pp. 668–672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. R. Margherio, R. R. Margherio, M. Hartzer, M. T. Trese, G. A. Williams, and P. J. Ferrone, “Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes,” Ophthalmology, vol. 105, no. 9, pp. 1617–1620, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. W. C. Wu, K. A. Drenser, M. Lai, A. Capone, and M. T. Trese, “Plasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity,” Retina, vol. 28, no. 3, supplement, pp. S75–S80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. W. C. Wu, K. A. Drenser, A. Capone, G. A. Williams, and M. T. Trese, “Plasmin enzyme-assisted vitreoretinal surgery in congenital X-linked retinoschisis: surgical techniques based on a new classification system,” Retina, vol. 27, no. 8, pp. 1079–1085, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. T. Trese, G. A. Williams, and M. K. Hartzer, “A new approach to stage 3 macular holes,” Ophthalmology, vol. 107, no. 8, pp. 1607–1611, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Sakuma, M. Tanaka, J. Inoue, A. Mizota, M. Souri, and A. Ichinose, “Efficacy of autologous plasmin for idiopathic macular hole surgery,” European Journal of Ophthalmology, vol. 15, no. 6, pp. 787–794, 2005. View at Scopus
  39. S. Rizzo, G. Pellegrini, F. Benocci, C. Belting, U. Baicchi, and M. Vispi, “Autologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgery,” Retina, vol. 26, no. 7, pp. 792–796, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Sakuma, M. Tanaka, J. Inoue, A. Mizota, M. Souri, and A. Ichinose, “Use of autologous plasmin during vitrectomy for diabetic maculopathy,” European Journal of Ophthalmology, vol. 16, no. 1, pp. 138–140, 2006. View at Scopus
  41. C. Azzolini, A. D'Angelo, G. Maestranzi et al., “Intrasurgical plasmin enzyme in diabetic macular edema,” American Journal of Ophthalmology, vol. 138, no. 4, pp. 560–566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Asami, H. Terasaki, S. Kachi et al., “Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema,” Ophthalmology, vol. 111, no. 2, pp. 231–237, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Hirata, A. Takano, Y. Inomata, N. Yonemura, N. Sagara, and H. Tanihara, “Plasmin-assisted vitrectomy for management of proliferative membrane in proliferative diabetic retinopathy: a pilot study,” Retina, vol. 27, no. 8, pp. 1074–1078, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. H. L. Wu, G. Y. Shi, and M. L. Bender, “Preparation and purification of microplasmin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 23, pp. 8292–8295, 1987. View at Scopus
  45. E. W. Schneider and M. W. Johnson, “Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review,” Clinical Ophthalmology, vol. 5, no. 1, pp. 1151–1165, 2011. View at Scopus
  46. A. Gandorfer, M. Rohleder, C. Sethi et al., “Posterior vitreous detachment induced by microplasmin,” Investigative Ophthalmology and Visual Science, vol. 45, no. 2, pp. 641–647, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Sakuma, M. Tanaka, A. Mizota, J. Inoue, and S. Pakola, “Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes,” Investigative Ophthalmology and Visual Science, vol. 46, no. 9, pp. 3295–3299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. M. D. De Smet, C. Valmaggia, J. Zarranz-Ventura, and B. Willekens, “Microplasmin: ex vivo characterization of its activity in porcine vitreous,” Investigative Ophthalmology and Visual Science, vol. 50, no. 2, pp. 814–819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. M. D. De Smet, C. Valmaggia, J. Zarranz-Ventura, and B. Willekens, “Microplasmin: ex vivo characterization of its activity in porcine vitreous,” Investigative Ophthalmology and Visual Science, vol. 50, no. 2, pp. 814–819, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Sakuma, M. Tanaka, A. Mizota, J. Inoue, and S. Pakola, “Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes,” Investigative Ophthalmology and Visual Science, vol. 46, no. 9, pp. 3295–3299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. W. Chen, X. Huang, X. W. Ma, W. Mo, W. J. Wang, and H. Y. Song, “Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator,” Eye, vol. 22, no. 2, pp. 300–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. D. F. Martin, M. G. Maguire, G. S. Ying, J. E. Grunwald, S. L. Fine, and G. J. Jaffe, “Ranibizumab and bevacizumab for neovascular age-related macular degeneration,” The New England Journal of Medicine, vol. 364, no. 20, pp. 1897–1908, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. D. T. Goldenberg, F. J. Giblin, M. Cheng et al., “Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes,” Retina, vol. 31, no. 2, pp. 393–400, 2011. View at Publisher · View at Google Scholar · View at Scopus